Mechanistic comparison of arachidonyl trifluoromethylketone and methoxyarachidonoyl fluorophosphonate based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
3
Shared Targets
43%
Jaccard Similarity
39%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
arachidonyl and methoxyarachidonoyl share 3 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.429 means 43% of the combined target set is bound by both compounds. The IDF-weighted score of 0.388 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do arachidonyl and methoxyarachidonoyl have in common?
arachidonyl and methoxyarachidonoyl share 3 molecular targets with a Jaccard similarity of 43%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can arachidonyl and methoxyarachidonoyl be combined?
arachidonyl and methoxyarachidonoyl share 3 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: arachidonyl or methoxyarachidonoyl?
In the BiohacksAI corpus: arachidonyl has 0 PubMed-indexed studies, methoxyarachidonoyl has 0 studies.